Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
07/10/1991 | CN1052868A Stabilization and maintenance of nerve growth factor biological activity by use of natural gangliosides or derivatives thereof |
07/10/1991 | CN1052858A New xanthine derivatives |
07/10/1991 | CN1013115B Process for preparing pyrimidoisoquinoline derivatives |
07/09/1991 | US5030715 Antibacterial agents; immunomodulators; auto immune diseases |
07/09/1991 | US5030643 Heterocyclic amide derivatives and use |
07/09/1991 | CA1285951C Naphthalenyl- and quinolinyl-amino substituted phenols |
07/04/1991 | DE4000084A1 Intravenoes applizierbare pharmazeutische zubereitung von et18-och(pfeil abwaerts)3(pfeil abwaerts) Intravenously administered pharmaceutical preparation of ET18-och (down arrow) 3 (down arrow) |
07/03/1991 | EP0435811A1 Xanthine derivatives |
07/03/1991 | EP0434844A1 New cyclic anthranilic acid derivative and method of producing the same |
07/03/1991 | EP0434827A1 Quinolinyl-benzopyran derivatives as antagonists of leukotriene d 4? |
07/03/1991 | EP0434759A1 Fluoro substituted benzocycloheptapyridine compounds, compositions and methods of use |
07/03/1991 | EP0434747A1 Viral vaccines |
07/03/1991 | EP0434744A1 Serum immunoregulatory polypeptide and uses therefor. |
07/03/1991 | EP0434721A1 Viral nucleotide sequences |
07/03/1991 | EP0434714A1 In position 3 substituted-5-beta-amidomethyl-oxazolidin-2-ones |
07/03/1991 | CN1052608A Bcrfl proteins as inhibitors of interferon-gamma |
07/02/1991 | US5028733 Prostaglandins |
07/02/1991 | US5028626 Peptides with pharmaceutical activity |
07/02/1991 | US5028615 Quinoline derivatives as antagonists of leukotriene D4 |
07/02/1991 | US5028607 Bis(aryl)alkene compounds |
07/02/1991 | US5028603 Platelet-Activating Factor Antagonist; Useful In Treatment Of Inflammatory Diseases, Allergic Diseases, Asthma, Respiratory System Disorders |
07/02/1991 | US5028593 Tuftsin analogs |
07/02/1991 | CA1285562C Quinone derivatives, their production and use |
07/02/1991 | CA1285479C Immunostimulant agents |
06/30/1991 | WO1991009857A1 Heterocyclic derivatives, method for preparing same, and their therapeutic applications |
06/28/1991 | WO1991009859A1 New xanthine derivatives |
06/27/1991 | WO1991009137A1 Recombinant thyrotropin receptor |
06/27/1991 | WO1991009059A1 Antibody antagonists of human interleukin-4 |
06/27/1991 | WO1991008760A1 Improved treatment of autoimmune diseases by aerosol administration of auto antigens |
06/26/1991 | EP0434450A2 Therapeutic nucleosides |
06/26/1991 | EP0434095A1 Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives |
06/26/1991 | EP0434094A1 Methods of using 2-isopropyl-2-phenylaminovaleronitriles immunosuppresants and vasodilators |
06/26/1991 | EP0434057A2 Indolocarbazole derivatives, processes for their preparation and their use |
06/26/1991 | EP0433827A2 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
06/26/1991 | EP0433766A1 Compositions of antiallergics and antihistamines and methods for their use |
06/26/1991 | EP0433765A1 The use of immunomodulants as synergistic agents of chemotherapeutics in tumor therapy |
06/26/1991 | EP0433744A1 Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration |
06/26/1991 | EP0433442A1 Hybrid molecules |
06/26/1991 | EP0433427A1 Combined use of n-imidazolyl derivatives of bicyclic compounds and cyclosporine in therapy |
06/26/1991 | EP0433353A1 Method and composition for the treatment and prevention of viral infections |
06/26/1991 | CN1052478A Lmproved process for preparing vinyl ethers |
06/25/1991 | US5026861 Antiarthritic asthma agent, lipoxygenase inhibitors |
06/25/1991 | US5026826 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use |
06/25/1991 | US5026711 Prevention and treatment of cardiovascular disorders and infections states; anxiolytic and anti-allergic agents |
06/25/1991 | US5026692 Use of sex hormone |
06/25/1991 | CA1285280C Quinone derivatives, their production and use |
06/23/1991 | CA2572802A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
06/22/1991 | WO1991009968A1 Cd3 specific recombinant antibody |
06/22/1991 | CA2033038A1 Methods of using 2-isopropyl-2-phenylaminovaleronitriles immunosuppressants and vasodilator |
06/22/1991 | CA2032827A1 Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives |
06/21/1991 | WO1991009127A1 BCRF1 PROTEINS AS INHIBITORS OF INTERFERON-$g(g) |
06/21/1991 | WO1991009048A1 Boronated nucleosides |
06/21/1991 | CA2071936A1 Boronated nucleosides |
06/19/1991 | EP0433267A2 Process for preparing eicosatetraynoic acid |
06/19/1991 | EP0433225A1 Process for the production of biologically active protein (e.g. TGF) |
06/19/1991 | EP0433127A2 Sulfated derivative of galactan extracted from Klebsiella, process for its preparation, application as medicines and pharmaceutical compositions containing it |
06/19/1991 | EP0433113A1 Stabilization and maintenance of the nerve growth factor biological activity by use of natural gangliosides or derivatives thereof |
06/19/1991 | EP0432984A2 Carbamoyl derivatives |
06/19/1991 | EP0432740A2 2-Substituted 4-(3-alkyl-5-tert.-butyl-4-hydroxy-phenyl)-thiazole, process for their preparation, medicaments containing them and their utilization |
06/19/1991 | EP0432510A1 Process for the preparation of genetic vectors for the nerve growth factor expression in eukaryotic cells |
06/19/1991 | EP0432490A2 Immunostimulant agent |
06/19/1991 | CA2031593A1 Compositions of antiallergics and antihistamines and methods for their use |
06/18/1991 | US5025034 Prostaglandins |
06/18/1991 | US5025028 Asthma |
06/18/1991 | US5024743 Prophylaxis and therapy of infectious diseases |
06/16/1991 | WO1991009036A1 Beta-lactam derivatives |
06/16/1991 | CA2071885A1 Beta-lactam derivatives |
06/16/1991 | CA2032282A1 2-substituted 4-(3-alkyl-5-tert.-butyl-4-hydroxyphenyl)thiazoles, processes for their preparation, pharmaceuticals containing them and their use |
06/15/1991 | WO1991009002A1 Process for the preparation of vinyl ethers |
06/15/1991 | CA2031394A1 Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration |
06/13/1991 | WO1991008298A2 Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
06/13/1991 | WO1991008291A2 Latency associated peptide and uses therefor |
06/13/1991 | WO1991008228A1 Leucocyte elastasis and cathepsin g-blocking peptide |
06/13/1991 | WO1991007988A1 Megakaryocyte production |
06/13/1991 | WO1991007955A1 Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders |
06/13/1991 | WO1991003248A3 Method for immune system activation |
06/12/1991 | EP0431519A1 System for transdermal albuterol administration |
06/12/1991 | EP0431069A1 Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3 |
06/12/1991 | CN1052117A Immunostimulating 6-aryl-5,6-dihydroimidazo (2.1-b) thiazole derivatives |
06/11/1991 | US5023364 Phenoxyalkylcarboxylic acid derivatives and process for their preparation |
06/11/1991 | US5023341 Acetylene thiochroman |
06/11/1991 | US5023340 Glycosidase inhibitors |
06/11/1991 | US5023263 42-oxorapamycin |
06/11/1991 | US5023255 Triazine derivatives; inhibitors exzyme 5-lipoxygenase |
06/05/1991 | WO1991008208A1 Heterocyclic substituted naphthyridinones and methods and compositions employing them |
06/05/1991 | EP0430771A1 Isoindolone derivatives, their preparation and their use as intermediates for the preparation of substance P antagonists |
06/05/1991 | EP0430334A1 Immunostimulating 6-aryl-5,6-dihydroimidazo[2,1-b]thiazole derivatives |
06/05/1991 | EP0430193A1 Monoclonal antibodies and their use |
06/05/1991 | EP0430029A2 Pyridin-2,4- and 2,5-dicarboxylic acid diamides, process for their preparation and their use |
06/05/1991 | EP0429627A1 Derivatives of quinoline-3-carboxanilide. |
06/05/1991 | EP0429544A1 Synthetic, anti-complement protein and the gene encoding same |
06/05/1991 | CN1051937A Stem cell factor |
06/05/1991 | CN1051934A Process for preparation of genelic vectors for nerve growth factor expression in eukaryotic cells |
06/05/1991 | CA2070400A1 Heterocyclic substituted naphthyridinones and methods and compositions employing them |
06/05/1991 | CA2031376A1 Single layer transdermal drug administration system |
06/05/1991 | CA2031320A1 Galactan sulfated derivative from klebsiella, a process for its preparation, its application as therapeutic agents and pharmaceuticals compositions containing the same |
06/04/1991 | US5021576 2-Anilino phenylacetic acid derivatives |
06/04/1991 | US5021549 Physiologically active substances, probestin and prostatin and production thereof |
06/04/1991 | US5021450 New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof |
06/04/1991 | US5021443 Noval benzimidazole and azabenzimiazole derivatives which are thromboxane receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present |